| |
CCR4+/CCR6+ Th/Th
|
CCR4+/CCR6+ Th/T
|
CCR4+/CCR6+ Th/L
|
Treg/Th
|
Treg/T
|
Treg/L
|
Fox-P3+/CD4+CD25+
|
|---|
|
ASp
|
9.81 ± 0.62
|
7.69 ± 0.63
|
4.24 ± 0.56
|
2.82 ± 0.24
|
2.12 ± 0.23
|
1.23 ± 0.13
|
22.23 ± 5.13
|
|
HD1
|
5.51 ± 0.59
|
3.53 ± 0.56
|
2.24 ± 0.48
|
5.27 ± 0.28
|
4.13 ± 0.26
|
2.54 ± 0.15
|
32.54 ± 7.05
|
|
HD2
|
5.34 ± 0.52
|
3.33 ± 0.45
|
2.17 ± 0.37
|
5.31 ± 0.23
|
4.21 ± 0.19
|
2.64 ± 0.18
|
34.92 ± 6.71
|
- Data presented as the percentage mean ± standard deviation. The differences for all percentages between patients with ankylosing spondylitis (ASp) and either HLA-B27-negative healthy donors (HD1) or HLA-B27-positive healthy donors (HD2) were significant (P < 0.001, according to a two-tailed significant level of 0.05). There were no significant differences between HD1 and HD2 (P > 0.05). Th, CD4+ T-helper cells; T, T lymphocytes; L, lymphocytes; Treg, forkhead box P3-positive regulatory T cells.
